Contactless Health Screening
Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run Testing On...
Focusing on novel uses, production and delivery forms of psilocybin as a next generation solution for mental illness, substance abuse and neurological disordersAdvancing to FDA clinical studies for methamphetamine use disorder and...
LIVE QUOTE
Toronto | July 28, 2021 – Today, NEO welcomes its newest corporate listing partner, Biomind Labs Inc. (“Biomind”), as it makes its public markets debut on the NEO Exchange. A...
Progress in the development of DMT-assisted therapy for the treatment of depression
LONDON, Aug. 9, 2021 /CNW/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a...
Ronan Levy, Field Trip Health Chairman, joins Yahoo Finance to discuss the psychedelic company’s debut on the Nasdaq and the development of the psychedelics.
VIDEO
Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low.Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical Trial With Mycotopia Therapies and PsyBioMed.Launching...
